1120 related articles for article (PubMed ID: 18070287)
21. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
22. TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrence.
Kim JH; Yu SJ; Park BL; Cheong HS; Pasaje CF; Bae JS; Lee HS; Shin HD; Kim YJ
Dig Dis; 2011; 29(3):278-83. PubMed ID: 21829018
[TBL] [Abstract][Full Text] [Related]
23. UGT1A7 haplotype is associated with an increased risk of hepatocellular carcinoma in hepatitis B carriers.
Kong SY; Ki CS; Yoo BC; Kim JW
Cancer Sci; 2008 Feb; 99(2):340-4. PubMed ID: 18271934
[TBL] [Abstract][Full Text] [Related]
24. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.
Kao JH; Chen PJ; Lai MY; Chen DS
Gastroenterology; 2003 Feb; 124(2):327-34. PubMed ID: 12557138
[TBL] [Abstract][Full Text] [Related]
25. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene.
Ho SY; Wang YJ; Chen HL; Chen CH; Chang CJ; Wang PJ; Chen HH; Guo HR
Cancer Causes Control; 2004 Sep; 15(7):657-63. PubMed ID: 15280623
[TBL] [Abstract][Full Text] [Related]
26. Integrin alpha V polymorphisms and haplotypes in a Korean population are associated with susceptibility to chronic hepatitis and hepatocellular carcinoma.
Lee SK; Kim MH; Cheong JY; Cho SW; Yang SJ; Kwack K
Liver Int; 2009 Feb; 29(2):187-95. PubMed ID: 18694400
[TBL] [Abstract][Full Text] [Related]
27. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus.
Miyazoe S; Hamasaki K; Nakata K; Kajiya Y; Kitajima K; Nakao K; Daikoku M; Yatsuhashi H; Koga M; Yano M; Eguchi K
Am J Gastroenterol; 2002 Aug; 97(8):2086-92. PubMed ID: 12190181
[TBL] [Abstract][Full Text] [Related]
28. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
[TBL] [Abstract][Full Text] [Related]
29. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.
Chan HL; Tse CH; Mo F; Koh J; Wong VW; Wong GL; Lam Chan S; Yeo W; Sung JJ; Mok TS
J Clin Oncol; 2008 Jan; 26(2):177-82. PubMed ID: 18182659
[TBL] [Abstract][Full Text] [Related]
30. Putative association of transforming growth factor-alpha polymorphisms with clearance of hepatitis B virus and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Kim YJ; Kim HY; Kim JS; Lee JH; Yoon JH; Kim CY; Park BL; Cheong HS; Bae JS; Kim S; Shin HD; Lee HS
J Viral Hepat; 2010 Jul; 17(7):518-26. PubMed ID: 19780938
[TBL] [Abstract][Full Text] [Related]
31. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
32. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma.
Chou YC; Yu MW; Wu CF; Yang SY; Lin CL; Liu CJ; Shih WL; Chen PJ; Liaw YF; Chen CJ
Gut; 2008 Jan; 57(1):91-7. PubMed ID: 17502344
[TBL] [Abstract][Full Text] [Related]
33. Association of TNF-α promoter polymorphisms with the outcome of persistent HBV infection in a northeast Chinese Han population.
Qiu B; Wang X; Zhang P; Shi C; Zhang J; Qiu W; Wang W; Li D
Acta Biochim Biophys Sin (Shanghai); 2012 Aug; 44(8):712-8. PubMed ID: 22695741
[TBL] [Abstract][Full Text] [Related]
34. Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma.
Lin CL; Liu CH; Chen W; Huang WL; Chen PJ; Lai MY; Chen DS; Kao JH
J Gastroenterol Hepatol; 2007 Jul; 22(7):1098-103. PubMed ID: 17608857
[TBL] [Abstract][Full Text] [Related]
35. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
[TBL] [Abstract][Full Text] [Related]
36. Association of interleukin-18 gene polymorphism (-607A/A genotype) with susceptibility to chronic hepatitis B virus infection.
Hirankarn N; Manonom C; Tangkijvanich P; Poovorawan Y
Tissue Antigens; 2007 Aug; 70(2):160-3. PubMed ID: 17610422
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.
Yu MW; Yeh SH; Chen PJ; Liaw YF; Lin CL; Liu CJ; Shih WL; Kao JH; Chen DS; Chen CJ
J Natl Cancer Inst; 2005 Feb; 97(4):265-72. PubMed ID: 15713961
[TBL] [Abstract][Full Text] [Related]
38. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.
Ito K; Tanaka Y; Orito E; Sugiyama M; Fujiwara K; Sugauchi F; Kato T; Tokita H; Izumi N; Kato M; Yuen MF; Lai CL; Gish RG; Ueda R; Mizokami M
Clin Infect Dis; 2006 Jan; 42(1):1-7. PubMed ID: 16323084
[TBL] [Abstract][Full Text] [Related]
39. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.
Tseng TC; Liu CJ; Chen PJ; Lai MY; Lin CL; Kao JH; Chen DS
Liver Int; 2007 Sep; 27(7):983-8. PubMed ID: 17696938
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
Lin CL; Kao JH
J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]